Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Inconsistent Measurement of Financial Distress in Cancer Patients

Publish date:: June 6, 2019

Key clinical point: Researchers found a lack of validated instruments to effectively measure the financial burden experienced by cancer patients in the current body of literature.

Major finding: After analysis, 6 distinct subdomains that characterized patient views and responses to financial distress were identified.

Study details: A systematic review that identified 40 studies related to financial distress in cancer patients.

Disclosures: The study was funded by IPSEN Pharma GmbH. The authors reported having no conflicts of interest.

Citation:

Witte J et al. Ann Oncol. 2019 May 2. doi: 10.1093/annonc/mdz140.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Patient & Survivor Care

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Reduced cancer mortality with Medicaid expansion,

Risk factors for severe immune-related AEs identified,

New cancer drugs may have saved more than 1.2 million Americans,